Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 11/20 | 0.61 |
| ▸ | NPC1 | O15118 | 7/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.61 |
| ▸ | MAPT | P10636 | 6/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.61 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.61 |
| ▸ | RELA | Q04206 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | GLA | P06280 | 3/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26535825 | 1.00 | RAB9A (0.61) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL26535744 | 1.00 | RAB9A (0.61) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL27258765 | 1.00 | RAB9A (0.61) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL26535962 | 0.98 | RAB9A (0.60) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL26535965 | 0.98 | RAB9A (0.60) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL26535967 | 0.96 | RAB9A (0.57) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL26535828 | 0.96 | RAB9A (0.57) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL12450340 | 0.94 | APP (0.60) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL17343993 | 0.91 | RAB9A (0.58) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL17343947 | 0.91 | APP (0.61) | RAB9ANPC1KDM4EMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNT1, CCNE2, SCO2 | RAB9A 3962/4885NPC1 1944/4885KDM4E 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.